Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
2 Supercharged Growth Stocks That Could Make You Richer
02:30pm, Wednesday, 09'th Aug 2023
Growth stocks have stormed back to life in recent weeks. Exact Sciences and Vertex Pharmaceuticals should benefit from this shift in sentiment, thanks to their strong innovation, rising sales, and ste
Is Vertex Pharmaceuticals Stock a Buy Now?
05:35am, Wednesday, 09'th Aug 2023
Vertex Pharmaceuticals is diversifying from making solely cystic fibrosis drugs. It could soon commercialize a pair of gene therapies for hereditary conditions.
2 Top Biotech Stocks to Buy in August
09:15am, Sunday, 06'th Aug 2023
Vertex's business should get a major boost in the coming years with new approvals. Eli Lilly's expanding portfolio of new products will help it maintain its recent momentum.
3 Top Healthcare Stocks to Buy for August
09:15am, Saturday, 05'th Aug 2023
Humana delivered better-than-expected second-quarter earnings. Vertex Pharmaceuticals has three potential blockbuster therapies on the way.
2 Nasdaq 100 Stocks That Are Surefire Buys in August and 1 to Avoid
05:21am, Friday, 04'th Aug 2023
The Nasdaq 100 has come roaring back after a tumultuous 2022. Two Nasdaq 100 companies have the competitive edges and sustained long-term catalysts needed to reward patient investors handsomely.
Here's Why Investors Should Buy These 2 Medical Stocks After Earnings
02:59am, Thursday, 03'rd Aug 2023
Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex Pharmaceuticals (VRTX) stock.
Vertex Pharmaceuticals (VRTX): A Fairly Valued Stock with Strong Growth Prospects
06:33pm, Wednesday, 02'nd Aug 2023
Vertex Pharmaceuticals Inc ( VRTX , Financial) saw a daily gain of 3.07%, with an Earnings Per Share (EPS) (EPS) of $12.56. But is the stock fairly valued?
Vertex (VRTX) Beats on Q2 Earnings & Sales, Raises '23 View
01:27pm, Wednesday, 02'nd Aug 2023
Vertex Pharmaceuticals' (VRTX) second-quarter 2023 earnings and sales beat estimates. Based on strong Trikafta uptake, management raises its financial guidance for 2023.
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2023 Earnings Call Transcript
10:53pm, Tuesday, 01'st Aug 2023
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Susie Lisa - CFA, Senior Vice President of Investor Relations Reshma
Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Top Estimates
06:40pm, Tuesday, 01'st Aug 2023
Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $3.89 per share, beating the Zacks Consensus Estimate of $3.85 per share. This compares to earnings of $3.60 per share a year ago.
Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength
04:47pm, Tuesday, 01'st Aug 2023
Vertex Pharmaceuticals raised its full-year sales forecast on Tuesday, banking on strong demand for its cystic fibrosis (CF) treatment.
3 Biotech Stocks to Buy Before the Breakout
05:14pm, Friday, 28'th Jul 2023
During this Q3 of 2023, there have been many changes to U.S. healthcare at different levels. At the state level, there were changes to gender-affirming care.
3 Biotech Stocks You Better Be Buying on Each and Every Dip
07:00am, Thursday, 27'th Jul 2023
Biotechnology is one of the most exciting and innovative sectors in the market, offering investors the potential for high returns coupled with groundbreaking discoveries. However, due to regulatory hu
If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names
01:23pm, Wednesday, 26'th Jul 2023
The biotechnology industry is simply amazing, always advancing and bringing new drugs to fight complicated and serious diseases. If you are thinking about investing in this sector, it is crucial to kn
2 No-Brainer Cathie Wood Stocks to Buy Right Now
11:15am, Wednesday, 26'th Jul 2023
Cathie Wood is having an exceptional 2023. Vertex Pharmaceuticals and Pfizer are two of Wood's holdings that stand out as top buys right now.
